By Professor Maree Hackett

Other

Loo C; Somogyi A; Alonzo A; Rodgers A; Baune B; Mihalopoulos C; Barton D; Hadzi-Pavlovic D; Martin D; Carter G; Leyden J; Lapidus K; Hackett M; Chatterton ML; Berk M; Mills N; Glozier N; Fitzgerald P; Glue P; Mitchell P; Hood S; Nikolin S; Dong V; Galvez-Ortiz V, 2021, Ketamine therapy among patients with treatment-resistant depression: a double-blind, randomised, controlled trial (The KADS Trial) - Clinical Trial Protocol & Statistical Analysis Plan, http://dx.doi.org/10.17605/OSF.IO/6FPGU

Back to profile page